Junming Yie

3.9k total citations · 1 hit paper
21 papers, 2.5k citations indexed

About

Junming Yie is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Junming Yie has authored 21 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Immunology and 4 papers in Oncology. Recurrent topics in Junming Yie's work include interferon and immune responses (8 papers), RNA Research and Splicing (7 papers) and Fibroblast Growth Factor Research (5 papers). Junming Yie is often cited by papers focused on interferon and immune responses (8 papers), RNA Research and Splicing (7 papers) and Fibroblast Growth Factor Research (5 papers). Junming Yie collaborates with scholars based in United States, China and Ireland. Junming Yie's co-authors include Dimitris Thanos, Theodora Agalioti, Stavros Lomvardas, Bhavin S. Parekh, Tom Maniatis, Kate Senger, Carlos Escalante, Aneel K. Aggarwal, Menie Merika and Guoying Chen and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Junming Yie

21 papers receiving 2.5k citations

Hit Papers

Ordered Recruitment of Chromatin Modifying and General Tr... 2000 2026 2008 2017 2000 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junming Yie United States 16 1.7k 873 467 460 208 21 2.5k
Anne E. Milner United Kingdom 26 1.2k 0.7× 668 0.8× 266 0.6× 758 1.6× 197 0.9× 44 2.3k
James D. Bretz United States 15 2.6k 1.5× 1.3k 1.5× 590 1.3× 617 1.3× 423 2.0× 24 3.3k
Marc Van de Craen Belgium 19 2.0k 1.2× 877 1.0× 381 0.8× 353 0.8× 433 2.1× 21 2.7k
Ivan Marazzi United States 14 2.1k 1.2× 718 0.8× 447 1.0× 326 0.7× 188 0.9× 19 2.7k
Tanya Goncharov Israel 7 2.8k 1.6× 1.2k 1.4× 628 1.3× 623 1.4× 444 2.1× 7 3.3k
Matthias Germer Germany 12 1.6k 0.9× 800 0.9× 370 0.8× 376 0.8× 283 1.4× 16 2.2k
Bénédicte Lemmers France 21 1.8k 1.1× 493 0.6× 384 0.8× 824 1.8× 199 1.0× 30 2.4k
Barbara Majello Italy 32 2.7k 1.6× 403 0.5× 408 0.9× 557 1.2× 245 1.2× 77 3.3k
Fei‐Long Meng China 22 1.7k 1.0× 753 0.9× 244 0.5× 313 0.7× 158 0.8× 48 2.3k
Futoshi Suizu Japan 20 1.4k 0.8× 617 0.7× 311 0.7× 511 1.1× 287 1.4× 44 2.0k

Countries citing papers authored by Junming Yie

Since Specialization
Citations

This map shows the geographic impact of Junming Yie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junming Yie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junming Yie more than expected).

Fields of papers citing papers by Junming Yie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junming Yie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junming Yie. The network helps show where Junming Yie may publish in the future.

Co-authorship network of co-authors of Junming Yie

This figure shows the co-authorship network connecting the top 25 collaborators of Junming Yie. A scholar is included among the top collaborators of Junming Yie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junming Yie. Junming Yie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Gang, et al.. (2023). Current state and challenges in respiratory syncytial virus drug discovery and development. Antiviral Research. 221. 105791–105791. 12 indexed citations
3.
Min, Xiaoshan, Junming Yie, Jinghong Wang, et al.. (2020). Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor. mAbs. 12(1). 1710047–1710047. 8 indexed citations
4.
Yie, Junming, et al.. (2020). Development of a robust functional cell-based assay for replacing the rabbit blood sugar bioidentity test of insulin glargine drug substance. Journal of Pharmaceutical and Biomedical Analysis. 186. 113328–113328. 3 indexed citations
5.
Stanislaus, Shanaka, Randy Hecht, Junming Yie, et al.. (2017). A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys. Endocrinology. 158(5). 1314–1327. 81 indexed citations
6.
Smith, Richard, Amy Duguay, Jennifer Weiszmann, et al.. (2013). A Novel Approach to Improve the Function of FGF21. BioDrugs. 27(2). 159–166. 19 indexed citations
7.
Bussiere, Jeanine L., Junming Yie, E. Allen Sickmier, et al.. (2013). Polyethylene Glycol Modified FGF21 Engineered to Maximize Potency and Minimize Vacuole Formation. Bioconjugate Chemistry. 24(6). 915–925. 53 indexed citations
8.
Yie, Junming, Wei Wang, Liying Deng, et al.. (2012). Understanding the Physical Interactions in the FGF21/FGFR/β‐Klotho Complex: Structural Requirements and Implications in FGF21 Signaling. Chemical Biology & Drug Design. 79(4). 398–410. 75 indexed citations
9.
Yie, Junming, Randy Hecht, Jennitte Stevens, et al.. (2008). FGF21 N‐ and C‐termini play different roles in receptor interaction and activation. FEBS Letters. 583(1). 19–24. 119 indexed citations
10.
Black, Shawn C., Dawn Kelly-Sullivan, Sergei Timofeevski, et al.. (2008). Pharmacological characterization of a small molecule inhibitor of c-Jun kinase. American Journal of Physiology-Endocrinology and Metabolism. 295(5). E1142–E1151. 22 indexed citations
11.
Mueller, Elisabetta, Stavit Drori, Junming Yie, et al.. (2002). Genetic Analysis of Adipogenesis through Peroxisome Proliferator-activated Receptor γ Isoforms. Journal of Biological Chemistry. 277(44). 41925–41930. 210 indexed citations
12.
Senger, Kate, Menie Merika, Theodora Agalioti, et al.. (2000). Gene Repression by Coactivator Repulsion. Molecular Cell. 6(4). 931–937. 65 indexed citations
13.
Agalioti, Theodora, Stavros Lomvardas, Bhavin S. Parekh, et al.. (2000). Ordered Recruitment of Chromatin Modifying and General Transcription Factors to the IFN-β Promoter. Cell. 103(4). 667–678. 609 indexed citations breakdown →
14.
Munshi, Nikhil, Junming Yie, Menie Merika, et al.. (1999). The IFN-  Enhancer: A Paradigm for Understanding Activation and Repression of Inducible Gene Expression. Cold Spring Harbor Symposia on Quantitative Biology. 64(0). 149–160. 54 indexed citations
15.
Yie, Junming. (1999). The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. The EMBO Journal. 18(11). 3074–3089. 144 indexed citations
16.
Munshi, Nikhil, Menie Merika, Junming Yie, et al.. (1998). Acetylation of HMG I(Y) by CBP Turns off IFNβ Expression by Disrupting the Enhanceosome. Molecular Cell. 2(4). 457–467. 285 indexed citations
17.
Escalante, Carlos, Junming Yie, Dimitris Thanos, & Aneel K. Aggarwal. (1998). Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature. 391(6662). 103–106. 338 indexed citations
18.
Escalante, Carlos, et al.. (1997). Expression, purification, and co‐crystallization of IRF‐I bound to the interferon‐β element PRD I. FEBS Letters. 414(2). 219–220. 10 indexed citations
19.
Yie, Junming, et al.. (1997). Intra- and Intermolecular Cooperative Binding of High-Mobility-Group Protein I(Y) to the Beta-Interferon Promoter. Molecular and Cellular Biology. 17(7). 3649–3662. 107 indexed citations
20.
Tsai, Eunice Y., Junming Yie, Dimitris Thanos, & Anne E. Goldfeld. (1996). Cell-Type-Specific Regulation of the Human Tumor Necrosis Factor Alpha Gene in B Cells and T Cells by NFATp and ATF-2/JUN. Molecular and Cellular Biology. 16(10). 5232–5244. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026